Ironwood Pharmaceuticals A Aktie
2,90
EUR
+0,12
EUR
+4,32
%
3,39
USD
+0,19
USD
+5,94
%
Ironwood Pharmaceuticals A jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Ironwood Pharmaceuticals A Aktie Analyse
| 25.02.19 | Ironwood Pharmaceuticals A Neutral | H.C. Wainwright & Co. | |
| 06.12.17 | Ironwood Pharmaceuticals A Neutral | Mizuho | |
| 22.02.17 | Ironwood Pharmaceuticals A Equal weight | Barclays Capital | |
| 24.10.16 | Ironwood Pharmaceuticals A Neutral | Wedbush Morgan Securities Inc. | |
| 27.09.16 | Ironwood Pharmaceuticals A Hold | WallachBeth | |
| 28.04.16 | Ironwood Pharmaceuticals A Neutral | Wedbush Morgan Securities Inc. | |
| 04.03.15 | Ironwood Pharmaceuticals A Equal weight | Barclays Capital | |
| 13.02.15 | Ironwood Pharmaceuticals A Hold | WallachBeth | |
|
Werbung
|
|||
Werbung
Werbung